|
Market Closed -
Euronext Bruxelles
16:55:00 16/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.002000 EUR | 0.00% |
|
0.00% | -13.04% |
| 09-23 | BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 27/10/25 | BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 1.5M 1.65M 1.39M 1.25M 2.36M 155M 2.45M 16.68M 6.61M 83.28M 6.2M 6.07M 264M | P/E 2023 |
-0.29x | P/E 2024 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 28.84M 31.74M 26.64M 24.07M 45.42M 2.98B 47.02M 320M 127M 1.6B 119M 117M 5.07B | EV / Sales 2023 |
113x | EV / Sales 2024 | 286x |
| Free-Float |
92.39% | Yield 2023 * |
-
| Yield 2024 | - |
Euronext BruxellesEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Bruxelles
| BIOS | Real-time | |
| 0R55 | Real-time | ||
| BOTHEb | Real-time |
| 6 months | -9.09% | ||
| Current year | -13.04% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.1 | |
| 5 years | 0 | 0.35 | |
| 10 years | 0 | 0.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 29/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 31/12/2021 | |
Eric Halioua
CHM | Chairman | - | 31/08/2025 |
Virginie Miath
BRD | Director/Board Member | - | 28/01/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -9.09% | -96.21% | 1.44M | ||
| -0.82% | +1.40% | +40.13% | +143.17% | 1,286B | ||
| -1.12% | +0.16% | +41.57% | +88.24% | 688B | ||
| -0.16% | +0.43% | +25.88% | +113.01% | 521B | ||
| +1.14% | +4.87% | +43.06% | +71.97% | 386B | ||
| -2.23% | -2.89% | +55.57% | +41.64% | 364B | ||
| +1.27% | +2.01% | +30.01% | +62.35% | 302B | ||
| +0.37% | +0.75% | +3.71% | +39.09% | 287B | ||
| -0.72% | -0.63% | +35.30% | +71.87% | 252B | ||
| -0.30% | -1.03% | +35.05% | +124.88% | 208B | ||
| Average | +0.10% | +1.87% | +30.12% | +66.00% | 429B | |
| Weighted average by Cap. | -0.12% | +3.26% | +36.53% | +98.00% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 336K 370K 310K 280K 529K 34.73M 548K 3.73M 1.48M 18.64M 1.39M 1.36M 59.03M | 102K 112K 94.24K 85.13K 161K 10.54M 166K 1.13M 449K 5.66M 421K 412K 17.92M |
| Net income | -28.78M -31.68M -26.59M -24.02M -45.32M -2.97B -46.92M -320M -127M -1.6B -119M -116M -5.06B | -4.77M -5.25M -4.41M -3.98M -7.51M -493M -7.77M -52.98M -20.99M -264M -19.69M -19.28M -838M |
| Net Debt | 28.04M 30.87M 25.91M 23.4M 44.16M 2.9B 45.72M 312M 123M 1.56B 116M 113M 4.93B | 27.34M 30.09M 25.26M 22.81M 43.05M 2.83B 44.57M 304M 120M 1.52B 113M 111M 4.8B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/11/26 | €0.002000 | 0.00% | 0 |
| 13/11/26 | €0.002000 | 0.00% | 0 |
| 12/11/26 | €0.002000 | 0.00% | 0 |
| 11/11/26 | €0.002000 | 0.00% | 0 |
| 10/11/26 | €0.002000 | 0.00% | 0 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BIOS Stock
Select your edition
All financial news and data tailored to specific country editions
















